GLAND PHARMA
Back to Income Statement
|
GLAND PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹772 Cr | ₹781 Cr | ₹1,212 Cr | ₹997 Cr | ₹773 Cr |
What is the latest Consolidated Net Profit of GLAND PHARMA ?
Year | Consolidated Net Profit |
---|---|
Mar2025 | ₹772 Cr |
Mar2024 | ₹781 Cr |
Mar2023 | ₹1,212 Cr |
Mar2022 | ₹997 Cr |
Mar2021 | ₹773 Cr |
How is Consolidated Net Profit of GLAND PHARMA Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2025 | ₹772 Cr | -1.10 | |
Mar2024 | ₹781 Cr | -35.54 | |
Mar2023 | ₹1,212 Cr | 21.54 | |
Mar2022 | ₹997 Cr | 29.00 | |
Mar2021 | ₹773 Cr | - |
Compare Consolidated Net Profit of peers of GLAND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAND PHARMA | ₹34,039.4 Cr | 2.5% | 10.7% | -0.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹409,219.0 Cr | 0.4% | 1.7% | 2% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,227.0 Cr | -0.3% | -3.8% | 35.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹126,643.0 Cr | 3.9% | 11.8% | 20% | Stock Analytics | |
CIPLA | ₹125,541.0 Cr | 1.5% | 3.8% | 2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,063.0 Cr | -0.5% | -0.1% | -5.1% | Stock Analytics |
GLAND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAND PHARMA | 2.5% |
10.7% |
-0.2% |
SENSEX | -1.2% |
-3% |
-0.2% |
You may also like the below Video Courses